Bermoprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C18H16O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CWU66767HF, chemically known as 10,11-dihydro-alpha,8-dimethyl-11-oxo-dibenz(b,f)oxepin-2-acetic acid but generally known as bermoprofen, which bears US NIH Compound Identifier 54204. European Medicines Agency schedules Bermoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05782MIG. The term BERMOPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). BERMOPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bermoprofen under HS 29329985 and SITC 51569. As of Q4 2014, BERMOPROFEN remains the US FDA Preferred Term for this commodity. Bermoprofen bears US NLM identifiers UMLS ID C0053340 and NCI Concept Code C73078. SMILES: O1C2C(CC(C(C)C(=O)O)CC2)C(=O)CC2C1CCC(C2)C.